GSK plc corrected the total number of voting rights on 2 April 2024, stating there are now 4,144,879,946 voting rights, with 4,314,051,101 total shares issued as of 31 March 2024. This is a significant event for shareholders as it impacts their notification requirements under regulatory rules.